[Genetic abnormality in thyroid cancers].
Yamashita
Shunichi
S
Department of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences.
D018263:Adenocarcinoma, Follicular / Q000235:genetics*; D000231:Adenocarcinoma, Papillary / Q000235:genetics*; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D009154:Mutation; D047495:PPAR gamma / Q000235:genetics; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics; D011956:Receptors, Cell Surface / Q000235:genetics; D043562:Receptors, G-Protein-Coupled; D013964:Thyroid Neoplasms / Q000235:genetics*; D000098706:Taste Receptors, Type 2
D047495:PPAR gamma; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D000098706:Taste Receptors, Type 2; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf